chr8-144429228-G-C

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_013432.5(TONSL):​c.4052C>G​(p.Ala1351Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000137 in 1,383,690 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 33)
Exomes 𝑓: 0.000014 ( 0 hom. )

Consequence

TONSL
NM_013432.5 missense

Scores

2
16

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.462

Publications

0 publications found
Variant links:
Genes affected
TONSL (HGNC:7801): (tonsoku like, DNA repair protein) The protein encoded by this gene is thought to be a negative regulator of NF-kappa-B mediated transcription. The encoded protein may bind NF-kappa-B complexes and trap them in the cytoplasm, preventing them from entering the nucleus and interacting with the DNA. Phosphorylation of this protein targets it for degradation by the ubiquitination pathway, which frees the NF-kappa-B complexes to enter the nucleus. [provided by RefSeq, Jul 2008]
TONSL Gene-Disease associations (from GenCC):
  • spondyloepimetaphyseal dysplasia, sponastrime type
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.14529142).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TONSLNM_013432.5 linkc.4052C>G p.Ala1351Gly missense_variant Exon 26 of 26 ENST00000409379.8 NP_038460.4 Q96HA7-1
TONSLXM_011517048.3 linkc.3080C>G p.Ala1027Gly missense_variant Exon 19 of 19 XP_011515350.1
TONSLXM_011517049.3 linkc.3044C>G p.Ala1015Gly missense_variant Exon 19 of 19 XP_011515351.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TONSLENST00000409379.8 linkc.4052C>G p.Ala1351Gly missense_variant Exon 26 of 26 1 NM_013432.5 ENSP00000386239.3 Q96HA7-1
TONSLENST00000497613.2 linkn.6154C>G non_coding_transcript_exon_variant Exon 17 of 17 2
ENSG00000305609ENST00000811933.1 linkn.199+1114G>C intron_variant Intron 1 of 1

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD4 exome
AF:
0.0000137
AC:
19
AN:
1383690
Hom.:
0
Cov.:
31
AF XY:
0.0000103
AC XY:
7
AN XY:
682520
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
31180
American (AMR)
AF:
0.00
AC:
0
AN:
35424
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25086
East Asian (EAS)
AF:
0.00
AC:
0
AN:
35438
South Asian (SAS)
AF:
0.00
AC:
0
AN:
78924
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
38530
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4606
European-Non Finnish (NFE)
AF:
0.0000176
AC:
19
AN:
1076854
Other (OTH)
AF:
0.00
AC:
0
AN:
57648
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.438
Heterozygous variant carriers
0
1
3
4
6
7
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
33

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Inborn genetic diseases Uncertain:1
Jun 09, 2022
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.4052C>G (p.A1351G) alteration is located in exon 26 (coding exon 26) of the TONSL gene. This alteration results from a C to G substitution at nucleotide position 4052, causing the alanine (A) at amino acid position 1351 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Benign
-0.17
T
BayesDel_noAF
Benign
-0.49
CADD
Benign
12
DANN
Benign
0.89
DEOGEN2
Benign
0.21
T
Eigen
Benign
-1.0
Eigen_PC
Benign
-1.1
FATHMM_MKL
Benign
0.15
N
M_CAP
Benign
0.052
D
MetaRNN
Benign
0.15
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Uncertain
2.3
M
PhyloP100
0.46
PrimateAI
Benign
0.41
T
PROVEAN
Benign
-2.3
N
REVEL
Benign
0.066
Sift
Benign
0.055
T
Sift4G
Uncertain
0.015
D
Polyphen
0.28
B
Vest4
0.24
MutPred
0.33
Loss of stability (P = 0.1862);
MVP
0.12
MPC
0.30
ClinPred
0.15
T
GERP RS
-1.4
Varity_R
0.024
gMVP
0.26
Mutation Taster
=98/2
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1823060639; hg19: chr8-145654611; API